Zobrazeno 1 - 6
of 6
pro vyhledávání: '"J R, Dingfelder"'
Publikováno v:
Prostaglandins.
A salastic vaginal device containing either 0.5% or 1.0% concentrations of 15(s)-15 methyl prostaglandin F2 alpha methyl ester was used to induce therapeutic abortion in 22 patients at 6-16 weeks gestation. The 1.0% device appeared to be an effacious
Publikováno v:
Fertility and sterility. 26(4)
Due to the need for an effective and safe parental administration technique, 2 intramuscular dose schedules of prostaglandin 15(S)ME2 were evaluated for practicability. 30 physically healthy women, ranging in age from 18-42 years, who were 8-22 menst
Autor:
W. E. Brenner, J. R. Dingfelder
Publikováno v:
Advances in contraception : the official journal of the Society for the Advancement of Contraception. 2(4)
Currently, there is no FDA approved treatment for bacterial vaginosis (BV), although various oral dosages of metronidazole are used to treat this condition. A vaginal therapeutic sponge (VLI Corporation) that releases metronidazole over a 24 h use pe
Publikováno v:
Advances in planned parenthood. 9
Publikováno v:
Fertility and sterility. 27(9)
Sixty gravidas 8 to 20 menstrual weeks' gestation were studied to evaluate (1) the efficacy of intramuscularly administered 15(S)-15-methyl prostaglandin F2alpha tromethamine (15(S)-Me-PGF2alpha) as an abortifacient; (2) the effectiveness of prochlor
Publikováno v:
The New England journal of medicine. 296(21)
A double-blind crossover study of 480 women taking either Ovral, Norinyl, or Norlestrin was conducted to determine the effects of missing 1 contraceptive tablet in the pill sequence on the incidence of breakthrough bleeding. The women were instructed